Navigation Links
EuroPharma Exclusive Distributor of BCM-95 and BosPure
Date:12/16/2009

GREEN BAY, Wis., Dec. 16 /PRNewswire/ -- EuroPharma, Inc. signs exclusive multi-year contract with DolCas Biotech for the use of super absorbency BCM-95® curcumin and specialized BosPure® boswellia in multiple EuroPharma formulations. The exclusive distribution territory for these clinically-studied ingredients includes both the health food store channel and professional channel, which includes allopathic doctors, chiropractors, naturopathic doctors, and clinics. BCM-95® is a highly absorbable curcumin. Human clinical data indicates that BCM-95 is up to 10 times more absorbable than curcumin 95% and 6.3 times more absorbable than curcumin with lecithin and piperine. BosPure® boswellia is beta-boswellic acid free, and standardized to contain 10-15% AKBA (Acetyl-11-Keto-Beta-Boswellic Acid), which enhances its targeted impact on the body's natural anti-inflammatory response.

Currently, EuroPharma distributes unique formulations that contain a combination of BCM-95 and BosPure: Curamin®, Curacel(TM), Dyflaminol(TM) and Bos-Cur(TM). EuroPharma also distributes an all-curcumin product, CuraMed(TM), containing 750 mgs of BCM-95 phospholipid complex, which is equivalent to up to 7,500 mgs of curcumin 95%. Due to consumer demand, they have also created a softgel containing 375 mg dose (equivalent to up to 3,700 mgs of curcumin 95%).

Curamin has rapidly become the number one pain* relieving formula in America, and has won the 2009 VityAward as best new supplement on the market, and both the 2008 and 2009 Best of Supplements awards.

Dyflaminol is recommended for support of a healthy anti-inflammatory response. Bos-Cur is indicated for balancing healthy leukotrienes, which are signaling substances intimately involved in a healthy inflammatory response. Curacel, which also contains resveratrol and green tea polyphenols, is recommended for healthy cellular function, particularly for breast, prostate, uterus and ovaries.

EuroPharma has agreed to support the marketing, promotion and distribution of BCM-95 and BosPure formulas with a targeted multi-million-dollar marketing investment. Terry Lemerond, President and Founder of EuroPharma, recognized the impact that curcumin can have on world health.

"There is no better health solution for what's ailing the world than curcumin. It plays a powerful role as an immune enhancer, inflammatory response balancer, liver protector, and is a powerful antioxidant, having a reported ORAC value of 159,722 per one hundred grams. Those are incredible numbers. People in India refer to curcumin as the 'all-in-one solution', and I agree," states Lemerond.

EuroPharma and DolCas Biotech express the mutual goal of having a major impact on the health of the world. Working in partnership, they expect their efforts to greatly increase their ability to get clinically-studied, specialized products into the hands of the people who need them most.

"We are proud to enter into this agreement, not only because BCM-95 curcumin and BosPure boswellia are cutting-edge breakthroughs in supplement research, but because we are proud to represent such a fine partner in DolCas Biotech," states Lemerond.

K.G. Rao, founder of DolCas Biotech, adds, "We are extremely proud to enter into this agreement with EuroPharma and founder Terry Lemerond because of his 40 years experience in the health food industry and proven success in developing operations on retail, wholesale, and manufacturing sides. We are delighted to enter into this agreement because Lemerond has so thoroughly recognized the excellent benefits of BCM-95 and BosPure and has committed his company's resources to furthering the advancement of BCM-95 to health food retail and professionals."

Further research is being conducted on BCM-95 and BosPure and results will be published in the very near future.

*occasional pain due to exercise or overuse.

EuroPharma offers clinically proven and effective nutritional supplements and natural remedies that improve the health of America. Throughout his 40-year career, President and Founder Terry Lemerond has created more than 300 high-quality formulations, all backed by scientific validation. Many are unique, proprietary and, in some cases, patented. Lemerond was the first to introduce glucosamine sulfate, IP-6, black cohosh for menopause, and the concept of botanical standardization to the U.S. health food market. At EuroPharma, Our Passion is Your Health(TM). For more information on EuroPharma and its entire product line, visit www.EuroPharmaUSA.com.

DolCas Biotech, LLC is a progressive research and development organization with a mission is to introduce pioneering ingredients into the nutraceutical industry that will aid in the research of curing modern ailments in the most holistic, yet progressive, methods. DolCas Biotech aims to foster the development of every peak performing ingredient from inception to fruition. Each endeavor is supported with their own clinical research data, thus giving partners in the industry complete confidence.

SOURCE EuroPharma, Inc.


'/>"/>
SOURCE EuroPharma, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. Pfenex Grants Exclusive License to Merck & Co., Inc. for the Production of Proteins for Undisclosed Vaccine Program
2. Ambry Genetics and SoftGenetics Form Exclusive Alliance for Extended Bioinformatics Support for Next Generation Sequencing Projects
3. Vanda Pharmaceuticals Announces Expiration of Hart-Scott -Rodino Waiting Period for Exclusive License of Fanapt(TM)
4. Health Robotics Reaches 100% Asia-Pacific Coverage Through its New Exclusive Distribution Contract With BioRobotics in Korea
5. Celling Technologies Signs Exclusive Agreement to Research and Develop Adipose Tissue Stem Cell Technology in Regenerative Medicine Institutes
6. Cumberland Pharmaceuticals and Phebra Pty Ltd. Sign Exclusive Agreement for Commercialization of Caldolor(R) in Australia and New Zealand
7. Octapharma Group and Fresenius Kabi Enter Into an Exclusive License, Development and Supply Agreement for a HESylated Recombinant Protein
8. Champions Biotechnology, Inc. Signs Exclusive Licensing Agreement with Ramot for TAR-1, a Novel Therapeutic for the Treatment of Cancer
9. Cardiac Science Expands into Vital Signs Market with Exclusive OMRON Healthcare Agreement
10. Baxa Corporation Signs Exclusive Distribution Agreement With Leading Pharmaceutical Corporation in Peoples Republic of China
11. Timm Medical Technologies and Ferring Pharmaceuticals Enter Exclusive Co-Promotion Agreement for Prosed(R) DS
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... , June 23, 2016 ... CAPR ), a biotechnology company focused on ... today announced that patient enrollment in its ongoing ... Duchenne) has exceeded 50% of its 24-patient target. ... in the third quarter of 2016, and to ...
(Date:6/23/2016)... , June 23, 2016 , ... on Thursday, July 7, 2016 , , , , LOCATION: ... , , , , EXPERT PANELISTS:  , , , ... Senior Industry Analyst, Christi Bird; Senior Industry Analyst, Divyaa Ravishankar and ... The global pharmaceutical industry is witnessing an exceptional era. ...
(Date:6/23/2016)... LONDON , June 23, 2016 ... environments  Oticon , industry leaders in ... the launch of Oticon Opn ™, the world,s ... world of possibilities for IoT devices.      ... Opn, Oticon introduces a number of ,world firsts,: ...
Breaking Medicine Technology:
(Date:6/27/2016)... ... 2016 , ... "FCPX editors can now reveal their media with growing colorful ... Christina Austin - CEO of Pixel Film Studios. , ProSlice Color brings the ... can now reveal the media of their split screens with growing colorful panels. , ...
(Date:6/26/2016)... ... ... Quality metrics are proliferating in cancer care, and are derived from many ... the beholder, according to experts who offered insights and commentary in the current issue ... the full issue, click here . , For the American Society of Clinical ...
(Date:6/26/2016)... ... June 26, 2016 , ... Many women are confused ... endometriosis. These women need a treatment plan to not only alleviate symptoms and ... help for preservation of fertility and ultimately achieving a pregnancy. The specialists at ...
(Date:6/25/2016)... ... 25, 2016 , ... First Choice Emergency Room , the largest network ... the Medical Director of its new Mesquite-Samuell Farm facility. , “We are pleased ... location,” said Dr. James M. Muzzarelli, Executive Medical Director of First Choice Emergency Room. ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... A recent ... that most people are unfamiliar with. The article goes on to state that individuals ... also many of these less common operations such as calf and cheek reduction. The ...
Breaking Medicine News(10 mins):